Chronic Spontaneous Urticaria: A Closer Look at Antinuclear Antibodies and Their Autoimmune Implications

1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-66.
2. Greiner B, Nicks S, Adame M, McCracken J. Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review. Clin Rev Allergy Immunol. 2022;63(3):381-9.
3. Ulambayar B, Park HS. Anti-TPO IgE Autoantibody in Chronic Urticaria: Is It Clinically Relevant? Allergy Asthma Immunol Res. 2019;11(1):1-3.
4. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation. Br J Dermatol. 1986;114(5):583-90.
5. Schmetzer O, Lakin E, Topal FA, Preusse P, Freier D, Church MK, Maurer M. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2018;142(3):876-82.
6. Schoepke N, Asero R, Ellrich A, Ferrer M, Gimenez-Arnau A, C EHG, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study. Allergy. 2019;74(12):2427-36.
7. Pluta-Kubicz M, Brzoza Z. Chronic Urticaria-Pathogenesis, Diagnostics, Therapy and Influence of Coexisting Angioedema. J Clin Med. 2023;12(2).
8. Sella JA, Ferriani MPL, Melo JML, Trevisan Neto O, Zanetti MET, Cordeiro DL, et al. Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU. J Allergy Clin Immunol Glob. 2023;2(4):100159.
9. Asero R, Marzano AV, Ferrucci S, Lorini M, Carbonelli V, Cugno M. Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria. Clin Exp Immunol. 2020;200(3):242-9.
10. Maronese CA, Ferrucci SM, Moltrasio C, Lorini M, Carbonelli V, Asero R, et al. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab. J Clin Med. 2023;12(1).
11. Magen E, Waitman DA, Dickstein Y, Davidovich V, Kahan NR. Clinical-laboratory characteristics of ANA-positive chronic idiopathic urticaria. Allergy Asthma Proc. 2015;36(2):138-44.
12. Arunkajohnsak S, Jiamton S, Tuchinda P, Chularojanamontri L, Rujitharanawong C, Chanchaemsri N, Kulthanan K. Do Antinuclear Antibodies Influence the Clinical Features of Chronic Spontaneous Urticaria?: A Retrospective Cohort Study. Biomed Res Int. 2022;2022:7468453.
13. Ertas R, Hawro T, Altrichter S, Ozyurt K, Erol K, Ketenci Ertas S, Maurer M. Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy. 2020;75(2):468-70.
14. Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957;96(3):575-9.
15. Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J. 1957;2(5047):732-4.
16. Lapolla W, Desai N, English JC, 3rd. Clinical utility of testing for autoimmunity in chronic idiopathic urticaria. J Am Acad Dermatol. 2012;66(3):e83-8.
17. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256-68.
18. Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879-89.
19. Ye YM, Park JW, Kim SH, Ban GY, Kim JH, Shin YS, et al. Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study. Allergy Asthma Immunol Res. 2016;8(2):115-23.
20. Viswanathan RK, Biagtan MJ, Mathur SK. The role of autoimmune testing in chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108(5):337-41 e1.
21. Calamita Z, Pela Calamita AB. Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence of antibodies. Inflamm Allergy Drug Targets. 2013;12(1):8-11.
22. Kolkhir P, Kovalkova E, Chernov A, Danilycheva I, Krause K, Sauer M, et al. Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE. J Allergy Clin Immunol Pract. 2021;9(11):4138-46 e8.
23. Karsten Conrad WS, Falk Hiepe, Marvin J. Fritzler. Autoantibodies in Systemic Autoimmune Diseases : A Diagnostic Reference 2007.
24. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest. 1993;91(4):1399-404.
25. Fujii T, Mimori T, Akizuki M. Detection of autoantibodies to nucleolar transcription factor NOR 90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays. Arthritis Rheum. 1996;39(8):1313-8.
26. Jang JH, Yang EM, Lee Y, Ye YM, Moon J, Ryu MS, Park HS. Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU). World Allergy Organ J. 2022;15(2):100629.

Comments (0)

No login
gif